111 related articles for article (PubMed ID: 1719682)
1. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
Ersbøll J
Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
[No Abstract] [Full Text] [Related]
2. [Growth factors in oncology: effectiveness and prospects].
Ottmann OG; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
[TBL] [Abstract][Full Text] [Related]
3. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
Spaëth D; Geoffrois L; Conroy T
Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
[No Abstract] [Full Text] [Related]
4. Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia.
Jørgensen HG; Copland M; Holyoake TL
Cancer; 2005 Jan; 103(1):210-11. PubMed ID: 15540243
[No Abstract] [Full Text] [Related]
5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
6. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
de la Rubia Comos J
Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
[No Abstract] [Full Text] [Related]
7. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic growth factors--not whether, but when and where.
Hoelzer D
N Engl J Med; 1997 Jun; 336(25):1822-4. PubMed ID: 9187075
[No Abstract] [Full Text] [Related]
9. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
10. [Indications for the use of granulocyte growth factors].
Elonen E
Duodecim; 1997; 113(22):2319-25. PubMed ID: 10892137
[No Abstract] [Full Text] [Related]
11. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
[No Abstract] [Full Text] [Related]
12. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
[TBL] [Abstract][Full Text] [Related]
13. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
Peddi VR; Hariharan S; Schroeder TJ; First MR
Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892
[TBL] [Abstract][Full Text] [Related]
14. Future strategy for cancer treatment using recombinant human granulocyte colony stimulating factor.
Diehl V
Eur J Cancer; 1994; 30A Suppl 3():S44-7. PubMed ID: 7535072
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
16. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
[No Abstract] [Full Text] [Related]
18. The role of granulocyte colony-stimulating factor with dose-intensive chemotherapy.
Ogawa M
Semin Oncol; 1994 Feb; 21(1 Suppl 1):7-9. PubMed ID: 7512279
[No Abstract] [Full Text] [Related]
19. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas].
Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J
Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975
[TBL] [Abstract][Full Text] [Related]
20. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
[No Abstract] [Full Text] [Related]
[Next] [New Search]